Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT6 Receptor Partial Agonist and Dopamine Transporter Inhibitor

Overview of attention for article published in Frontiers in Neuroscience, February 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 73,571 followers.

Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT6 Receptor Partial Agonist and Dopamine… https://t.co/uUqZVLkhDZ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.